Cumberland Pharmaceuticals

(NASDAQ) CPIX

Current Price$6.11

Market Cap$90.65M

Since IPO (2009)-64%

5 Year+87%

1 Year+83%

1 Month+3%

Cumberland Pharmaceuticals Financials at a Glance

Market Cap

$90.65M

Revenue (TTM)

$41.94M

Net Income (TTM)

-$7.23M

EPS (TTM)

-$0.49

P/E Ratio

-12.26

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$6.11

Volume

213

Open

$6.12

Price

$6.11

Volume

213

Open

$6.12

Previous Close

$6.05

Daily Range

$6.11 - $6.21

52-Week Range

$1.85 - $6.61

Estimated Earnings Date

Aug 4, 2026

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$6.11

Volume

213

Open

$6.12

Previous Close

$6.05

Daily Range

$6.11 - $6.21

52-Week Range

$1.85 - $6.61

Estimated Earnings Date

Aug 4, 2026

CPIX News

Cumberland (CPIX) Q2 Revenue Up 10%

Motley Fool Markets TeamAug 6, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cumberland Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

A. J. Kazimi, MBA

Website

www.cumberlandpharma.com

Headquarters

Nashville, TN 37203, US

CPIX Financials

Key Financial Metrics (TTM)

Gross Margin

82.89%

Operating Margin

-17.20%

Net Income Margin

-17.24%

Return on Equity

-28.75%

Return on Capital

-7.96%

Return on Assets

-10.19%

Earnings Yield

-8.16%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$90.65M

Shares Outstanding

14.98M

Volume

213

Avg. Volume

967.53K

Financials (TTM)

Gross Profit

$34.76M

Operating Income

-$7.21M

EBITDA

-$1.82M

Operating Cash Flow

$1.42M

Capital Expenditure

-$94.12K

Free Cash Flow

$1.33M

Cash & ST Invst.

$11.01M

Total Debt

$10.07M

Cumberland Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$9.13M

-22.0%

Gross Profit

$7.20M

-30.0%

Gross Margin

78.82%

N/A

Market Cap

$90.65M

N/A

Market Cap/Employee

$996.13K

N/A

Employees

N/A

Net Income

-$3.14M

-349.7%

EBITDA

-$1.77M

-164.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$11.01M

-27.1%

Total Debt

$10.07M

-3.6%

Accounts Receivable

$14.26M

+36.0%

Inventory

$5.45M

+33.1%

Long Term Debt

$9.58M

-4.8%

Short Term Debt

$485.16K

+30.7%

Return on Assets

-10.19%

N/A

Return on Invested Capital

-19.76%

N/A

Free Cash Flow

$387.03K

-89.9%

Operating Cash Flow

$387.03K

-90.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LTRNLantern Pharma Inc.

LTRNLantern Pharma Inc.$3.71-6.08%

LVTXLAVA Therapeutics N.V.

LVTXLAVA Therapeutics N.V.$1.74-3.87%

DYAIDyadic International, Inc.

DYAIDyadic International, Inc.$0.80+8.89%

RMTIRockwell Medical, Inc.

RMTIRockwell Medical, Inc.$0.69+1.07%

ABVCABVC BioPharma, Inc.

ABVCABVC BioPharma, Inc.$1.41+6.02%

QNTMQuantum BioPharma Ltd.

QNTMQuantum BioPharma Ltd.$4.03+3.07%

CELUCelularity Inc.

CELUCelularity Inc.$0.69+2.75%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

WENWendy's

WENWendy's$7.32-0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.48+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.88-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.52+0.01%

AALAmerican Airlines Group

AALAmerican Airlines Group$17.84+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.49+0.04%

FCUVFocus Universal

FCUVFocus Universal$5.82+0.32%

Questions About CPIX

What is the current price of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals is trading at $6.11 per share.

What is the 52-week range for Cumberland Pharmaceuticals?

Over the past 52 weeks, Cumberland Pharmaceuticals has traded between $1.85 and $6.61.

How much debt does Cumberland Pharmaceuticals have?

As of the most recent reporting period, Cumberland Pharmaceuticals reported total debt of $10.07M.

How much cash does Cumberland Pharmaceuticals have on hand?

Cumberland Pharmaceuticals reported $11.01M in cash and cash equivalents in its most recent financial results.

What is Cumberland Pharmaceuticals’s dividend yield?

Cumberland Pharmaceuticals does not currently have a dividend yield.

Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Financials at a Glance

CPIX News

Cumberland (CPIX) Q2 Revenue Up 10%

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cumberland Pharmaceuticals

CPIX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cumberland Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CPIX

What is the current price of Cumberland Pharmaceuticals?

What is the 52-week range for Cumberland Pharmaceuticals?

How much debt does Cumberland Pharmaceuticals have?

How much cash does Cumberland Pharmaceuticals have on hand?

What is Cumberland Pharmaceuticals’s dividend yield?

Premium Investing Services